Infertility Treatment Market By Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries, Other Procedures) , By Patient Type (Female Infertility Treatment, Male Infertility Treatment) By End User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, Research Institutes) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Infertility Treatment Market Expected to Garner $3.8 Billion by 2033, Growing at a CAGR of 8.6%
The global infertility treatment market is expected to grow primarily due to the increasing acceptance of assisted reproductive technologies and the growing demand for genetic testing to prevent hereditary diseases. The Asia-Pacific region is predicted to witness profitable growth by 2033.
As per the report published by Research Dive, the global infertility treatment market was valued at $1.7 billion in 2023 and is expected to register a revenue of $3.8 billion by 2033 at a CAGR of 8.6% during the forecast period 2024-2033.
Dynamics of the Market
The increasing awareness & acceptance of assisted reproductive technologies, growing demand for genetic testing to prevent hereditary diseases, and policies promoting fertility treatments are expected to make the infertility treatment market a highly profitable one in the forecast period. Besides, lifestyle factors contributing to infertility, such as obesity & smoking are further boosting the market growth.
However, according to market analysts, legal restrictions on certain infertility treatments and disparities in access to reproductive healthcare services might restrain the growth of the market.
Technological innovations improving IVF outcomes and accessibility and advancements in third party IVF services present significant opportunities for infertility treatment market growth. Moreover, advancements in genomic testing are reducing genetic disorders during IVF, increasing its attractiveness on a global scale.
Key Players of the Market
The major players of the infertility treatment market include Thermo Fisher Scientific, Vitrolife, Cook Group, Baker Company INC., Genea Biomedx Ltd., Hamilton Thorne Ltd., Esco Micro Pte Ltd., FUJIFILM Irvine Scientific, and IVFtech APS.
What the Report Covers
In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).
Key Market Segments
By Patient Type
Female Infertility Treatment
Male Infertility Treatment
By End User
Fertility Centers
Hospitals Surgical Clinics
Cryobanks
Research Institutes
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
Italy
Spain
UK
France
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
UAE
South Africa
Rest of LAMEA
By Procedure
Assisted Reproductive Technology
Artificial Insemination
Fertility Surgeries
Other Procedures
Key Market Players
Thermo Fisher Scientific Inc.
Baker Company INC
vitrolife
Cook Group
Genea Biomedx Ltd.
Esco Micro Pte Ltd.
Hamilton Thorne Ltd.
FUJIFILM Irvine Scientific
IVFtech ApS
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: INFERTILITY TREATMENT MARKET, BY PROCEDURE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Procedure
- 4.2. Assisted Reproductive Technology
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Artificial Insemination
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Fertility Surgeries
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Other Procedures
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- CHAPTER 5: INFERTILITY TREATMENT MARKET, BY PATIENT TYPE
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Patient Type
- 5.2. Female Infertility Treatment
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Male Infertility Treatment
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: INFERTILITY TREATMENT MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Fertility Centers
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Hospitals Surgical Clinics
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Cryobanks
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Research Institutes
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- CHAPTER 7: INFERTILITY TREATMENT MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Procedure
- 7.2.3. Market Size and Forecast, By Patient Type
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Infertility Treatment Market
- 7.2.6.1. Market Size and Forecast, By Procedure
- 7.2.6.2. Market Size and Forecast, By Patient Type
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Infertility Treatment Market
- 7.2.7.1. Market Size and Forecast, By Procedure
- 7.2.7.2. Market Size and Forecast, By Patient Type
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Infertility Treatment Market
- 7.2.8.1. Market Size and Forecast, By Procedure
- 7.2.8.2. Market Size and Forecast, By Patient Type
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Procedure
- 7.3.3. Market Size and Forecast, By Patient Type
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Infertility Treatment Market
- 7.3.6.1. Market Size and Forecast, By Procedure
- 7.3.6.2. Market Size and Forecast, By Patient Type
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Italy Infertility Treatment Market
- 7.3.7.1. Market Size and Forecast, By Procedure
- 7.3.7.2. Market Size and Forecast, By Patient Type
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Spain Infertility Treatment Market
- 7.3.8.1. Market Size and Forecast, By Procedure
- 7.3.8.2. Market Size and Forecast, By Patient Type
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. UK Infertility Treatment Market
- 7.3.9.1. Market Size and Forecast, By Procedure
- 7.3.9.2. Market Size and Forecast, By Patient Type
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. France Infertility Treatment Market
- 7.3.10.1. Market Size and Forecast, By Procedure
- 7.3.10.2. Market Size and Forecast, By Patient Type
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Infertility Treatment Market
- 7.3.11.1. Market Size and Forecast, By Procedure
- 7.3.11.2. Market Size and Forecast, By Patient Type
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Procedure
- 7.4.3. Market Size and Forecast, By Patient Type
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Infertility Treatment Market
- 7.4.6.1. Market Size and Forecast, By Procedure
- 7.4.6.2. Market Size and Forecast, By Patient Type
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Infertility Treatment Market
- 7.4.7.1. Market Size and Forecast, By Procedure
- 7.4.7.2. Market Size and Forecast, By Patient Type
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Infertility Treatment Market
- 7.4.8.1. Market Size and Forecast, By Procedure
- 7.4.8.2. Market Size and Forecast, By Patient Type
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Infertility Treatment Market
- 7.4.9.1. Market Size and Forecast, By Procedure
- 7.4.9.2. Market Size and Forecast, By Patient Type
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Infertility Treatment Market
- 7.4.10.1. Market Size and Forecast, By Procedure
- 7.4.10.2. Market Size and Forecast, By Patient Type
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Infertility Treatment Market
- 7.4.11.1. Market Size and Forecast, By Procedure
- 7.4.11.2. Market Size and Forecast, By Patient Type
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Procedure
- 7.5.3. Market Size and Forecast, By Patient Type
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Infertility Treatment Market
- 7.5.6.1. Market Size and Forecast, By Procedure
- 7.5.6.2. Market Size and Forecast, By Patient Type
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Infertility Treatment Market
- 7.5.7.1. Market Size and Forecast, By Procedure
- 7.5.7.2. Market Size and Forecast, By Patient Type
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. UAE Infertility Treatment Market
- 7.5.8.1. Market Size and Forecast, By Procedure
- 7.5.8.2. Market Size and Forecast, By Patient Type
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. South Africa Infertility Treatment Market
- 7.5.9.1. Market Size and Forecast, By Procedure
- 7.5.9.2. Market Size and Forecast, By Patient Type
- 7.5.9.3. Market Size and Forecast, By End User
- 7.5.10. Rest of LAMEA Infertility Treatment Market
- 7.5.10.1. Market Size and Forecast, By Procedure
- 7.5.10.2. Market Size and Forecast, By Patient Type
- 7.5.10.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Thermo Fisher Scientific Inc.
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Baker Company INC
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Vitrolife
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Cook Group
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Genea Biomedx Ltd.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Esco Micro Pte Ltd.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Hamilton Thorne Ltd.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. FUJIFILM Irvine Scientific
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. IVFtech ApS
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 2. INFERTILITY TREATMENT MARKET FOR ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. INFERTILITY TREATMENT MARKET FOR ARTIFICIAL INSEMINATION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. INFERTILITY TREATMENT MARKET FOR FERTILITY SURGERIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. INFERTILITY TREATMENT MARKET FOR OTHER PROCEDURES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. GLOBAL INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 7. INFERTILITY TREATMENT MARKET FOR FEMALE INFERTILITY TREATMENT, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. INFERTILITY TREATMENT MARKET FOR MALE INFERTILITY TREATMENT, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. GLOBAL INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 10. INFERTILITY TREATMENT MARKET FOR FERTILITY CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. INFERTILITY TREATMENT MARKET FOR HOSPITALS SURGICAL CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. INFERTILITY TREATMENT MARKET FOR CRYOBANKS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. INFERTILITY TREATMENT MARKET FOR RESEARCH INSTITUTES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. INFERTILITY TREATMENT MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA INFERTILITY TREATMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 18. NORTH AMERICA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 19. U.S. INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 21. U.S. INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. CANADA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 23. CANADA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 24. CANADA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 25. MEXICO INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 26. MEXICO INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 27. MEXICO INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 28. EUROPE INFERTILITY TREATMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 30. EUROPE INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 31. EUROPE INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. GERMANY INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 33. GERMANY INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 34. GERMANY INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 35. ITALY INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 36. ITALY INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 37. ITALY INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 38. SPAIN INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 39. SPAIN INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 40. SPAIN INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. UK INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 42. UK INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 43. UK INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 44. FRANCE INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 45. FRANCE INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 46. FRANCE INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. REST OF EUROPE INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF EUROPE INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 49. REST OF EUROPE INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 50. ASIA-PACIFIC INFERTILITY TREATMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 52. ASIA-PACIFIC INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 53. ASIA-PACIFIC INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. CHINA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 55. CHINA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 56. CHINA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 57. JAPAN INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 58. JAPAN INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 59. JAPAN INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 60. INDIA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 61. INDIA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 62. INDIA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 63. SOUTH KOREA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 64. SOUTH KOREA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 65. SOUTH KOREA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 66. AUSTRALIA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 67. AUSTRALIA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 68. AUSTRALIA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 69. REST OF ASIA-PACIFIC INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 70. REST OF ASIA-PACIFIC INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 71. REST OF ASIA-PACIFIC INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 72. LAMEA INFERTILITY TREATMENT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 74. LAMEA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 75. LAMEA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 76. BRAZIL INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 77. BRAZIL INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 78. BRAZIL INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 79. SAUDI ARABIA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 80. SAUDI ARABIA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 81. SAUDI ARABIA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 82. UAE INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 83. UAE INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 84. UAE INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 85. SOUTH AFRICA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 86. SOUTH AFRICA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 87. SOUTH AFRICA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 88. REST OF LAMEA INFERTILITY TREATMENT MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
- TABLE 89. REST OF LAMEA INFERTILITY TREATMENT MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION)
- TABLE 90. REST OF LAMEA INFERTILITY TREATMENT MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 91. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
- TABLE 92. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
- TABLE 93. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
- TABLE 94. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
- TABLE 95. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 96. BAKER COMPANY INC: KEY EXECUTIVES
- TABLE 97. BAKER COMPANY INC: COMPANY SNAPSHOT
- TABLE 98. BAKER COMPANY INC: OPERATING SEGMENTS
- TABLE 99. BAKER COMPANY INC: PRODUCT PORTFOLIO
- TABLE 100. BAKER COMPANY INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 101. VITROLIFE: KEY EXECUTIVES
- TABLE 102. VITROLIFE: COMPANY SNAPSHOT
- TABLE 103. VITROLIFE: OPERATING SEGMENTS
- TABLE 104. VITROLIFE: PRODUCT PORTFOLIO
- TABLE 105. VITROLIFE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 106. COOK GROUP: KEY EXECUTIVES
- TABLE 107. COOK GROUP: COMPANY SNAPSHOT
- TABLE 108. COOK GROUP: OPERATING SEGMENTS
- TABLE 109. COOK GROUP: PRODUCT PORTFOLIO
- TABLE 110. COOK GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 111. GENEA BIOMEDX LTD.: KEY EXECUTIVES
- TABLE 112. GENEA BIOMEDX LTD.: COMPANY SNAPSHOT
- TABLE 113. GENEA BIOMEDX LTD.: OPERATING SEGMENTS
- TABLE 114. GENEA BIOMEDX LTD.: PRODUCT PORTFOLIO
- TABLE 115. GENEA BIOMEDX LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 116. ESCO MICRO PTE LTD.: KEY EXECUTIVES
- TABLE 117. ESCO MICRO PTE LTD.: COMPANY SNAPSHOT
- TABLE 118. ESCO MICRO PTE LTD.: OPERATING SEGMENTS
- TABLE 119. ESCO MICRO PTE LTD.: PRODUCT PORTFOLIO
- TABLE 120. ESCO MICRO PTE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 121. HAMILTON THORNE LTD.: KEY EXECUTIVES
- TABLE 122. HAMILTON THORNE LTD.: COMPANY SNAPSHOT
- TABLE 123. HAMILTON THORNE LTD.: OPERATING SEGMENTS
- TABLE 124. HAMILTON THORNE LTD.: PRODUCT PORTFOLIO
- TABLE 125. HAMILTON THORNE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 126. FUJIFILM IRVINE SCIENTIFIC: KEY EXECUTIVES
- TABLE 127. FUJIFILM IRVINE SCIENTIFIC: COMPANY SNAPSHOT
- TABLE 128. FUJIFILM IRVINE SCIENTIFIC: OPERATING SEGMENTS
- TABLE 129. FUJIFILM IRVINE SCIENTIFIC: PRODUCT PORTFOLIO
- TABLE 130. FUJIFILM IRVINE SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 131. IVFTECH APS: KEY EXECUTIVES
- TABLE 132. IVFTECH APS: COMPANY SNAPSHOT
- TABLE 133. IVFTECH APS: OPERATING SEGMENTS
- TABLE 134. IVFTECH APS: PRODUCT PORTFOLIO
- TABLE 135. IVFTECH APS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL INFERTILITY TREATMENT MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF INFERTILITY TREATMENT MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN INFERTILITY TREATMENT MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALINFERTILITY TREATMENT MARKET
- FIGURE 10. GLOBAL INFERTILITY TREATMENT MARKET SEGMENTATION, BY PROCEDURE
- FIGURE 11. INFERTILITY TREATMENT MARKET FOR ASSISTED REPRODUCTIVE TECHNOLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. INFERTILITY TREATMENT MARKET FOR ARTIFICIAL INSEMINATION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. INFERTILITY TREATMENT MARKET FOR FERTILITY SURGERIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. INFERTILITY TREATMENT MARKET FOR OTHER PROCEDURES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. GLOBAL INFERTILITY TREATMENT MARKET SEGMENTATION, BY PATIENT TYPE
- FIGURE 16. INFERTILITY TREATMENT MARKET FOR FEMALE INFERTILITY TREATMENT, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. INFERTILITY TREATMENT MARKET FOR MALE INFERTILITY TREATMENT, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. GLOBAL INFERTILITY TREATMENT MARKET SEGMENTATION, BY END USER
- FIGURE 19. INFERTILITY TREATMENT MARKET FOR FERTILITY CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. INFERTILITY TREATMENT MARKET FOR HOSPITALS SURGICAL CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. INFERTILITY TREATMENT MARKET FOR CRYOBANKS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. INFERTILITY TREATMENT MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 27. COMPETITIVE DASHBOARD
- FIGURE 28. COMPETITIVE HEATMAP: INFERTILITY TREATMENT MARKET
- FIGURE 29. TOP PLAYER POSITIONING, 2023
- FIGURE 30. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. BAKER COMPANY INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. BAKER COMPANY INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. BAKER COMPANY INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. VITROLIFE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. VITROLIFE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. VITROLIFE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. COOK GROUP: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. COOK GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. COOK GROUP: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. GENEA BIOMEDX LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. GENEA BIOMEDX LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. GENEA BIOMEDX LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. ESCO MICRO PTE LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. ESCO MICRO PTE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. ESCO MICRO PTE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. HAMILTON THORNE LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. HAMILTON THORNE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. HAMILTON THORNE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. FUJIFILM IRVINE SCIENTIFIC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 52. FUJIFILM IRVINE SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. FUJIFILM IRVINE SCIENTIFIC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. IVFTECH APS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 55. IVFTECH APS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. IVFTECH APS: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook